EU Tightens Supply‑Chain Rules, Targets Chinese Firms in Critical Sectors

Lead

The European Union announced a suite of procurement and cybersecurity rules that will exclude Chinese medical device manufacturers from public tenders over €5 million and require EU firms to source components from at least three non‑Chinese suppliers. At the same time, two leading prediction‑market platforms, Kalshi and Polymarket, have begun accepting users from India without obtaining local licences, positioning themselves as a duopoly in one of the world’s largest betting markets.

Background

European supply chains have long relied on Chinese manufacturers for critical components, especially in batteries, clean‑tech and medical devices. Brussels has cited security and fair‑competition concerns, arguing that dependence on a single country could expose the bloc to geopolitical risk. The EU’s new rules are part of a broader effort to reduce that dependence and to enforce stricter controls on foreign investment in sectors where China dominates production.

In the financial services arena, prediction markets have grown rapidly, with global trading volumes exceeding $4.8 billion per week across the two largest platforms. India, with a population of 1.4 billion, represents a vast untapped market for betting and wagering, yet has historically been avoided by Western platforms due to regulatory uncertainty.

What Happened

Under Regulation 2025/1197, effective 30 June 2025, Chinese medical device manufacturers will be excluded from EU public tenders valued at more than €5 million. Where Chinese firms can still participate, their share will be capped at 50 % by value. The procurement rules are expected to apply to all EU contracting authorities, with possible exceptions for smaller local authorities and specific cases where public interest demands flexibility.

Simultaneously, the EU is revising its Cybersecurity Act, potentially classifying several suppliers as “high‑risk.” The designation would mainly target Chinese companies and affect 18 critical sectors, with an estimated economic impact of €367.8 billion over five years.

The Industrial Accelerator Act imposes stringent conditions on foreign investors in sectors where China dominates, particularly batteries and clean‑tech. Investors from countries controlling more than 40 % of global markets in these industries—effectively China—would face technology‑transfer and local‑production commitments.

In the prediction‑market space, both Kalshi and Polymarket have quietly opened their platforms to Indian residents. Neither has established a legal entity in India or obtained a local licence. Kalshi, regulated by the U.S. Commodity Futures Trading Commission, processes roughly $2.7 billion in weekly trades across more than 350,000 active markets. Polymarket, a crypto‑native competitor, handles slightly over $2.1 billion in weekly trades. Together, the two platforms account for more than $4.8 billion in weekly trading volume.

Market & Industry Implications

EU procurement rules are expected to increase costs for European companies and consumers, as suppliers may need to diversify away from Chinese sources. The €367.8 billion projected cost of the cybersecurity regulation alone suggests meaningful margin pressure in medical devices, clean energy, telecommunications and critical infrastructure. Companies in these sectors will face more complex and expensive procurement processes.

Chinese firms producing 80 % of the world’s solar panels and dominating lithium‑ion battery manufacturing may need to establish local production facilities and share technology to maintain access to the European market, according to the Industrial Accelerator Act.

In India, the entry of Kalshi and Polymarket could accelerate betting activity, especially around high‑profile events such as the Indian Premier League (IPL). The platforms’ lack of local licences means they are betting on regulatory ambiguity, potentially exposing them to future enforcement actions.

The prediction‑market sector has seen over 1,000 % annual growth, and both platforms are valued above $10 billion each. Their combined weekly trading volume demonstrates the scale of the market they are tapping into.

What to Watch

• 30 June 2025: Effective date of Regulation 2025/1197, excluding Chinese medical device manufacturers from large public tenders.

• Upcoming EU Cybersecurity Act revision: Potential classification of suppliers as high‑risk and the resulting impact on 18 critical sectors.

• Implementation of the Industrial Accelerator Act: Requirements for foreign investors in batteries and clean‑tech, including technology transfers and local production commitments.

• Regulatory developments in India concerning unlicensed foreign betting platforms: Possible enforcement actions against Kalshi and Polymarket.

• Monitoring of market responses: Changes in procurement costs for EU firms and shifts in betting volumes in India following the platforms’ entry.